admin1

AFFINITY

Assessment of fluoxetine in stroke recovery trial Lead PI:  Prof Graeme J Hankey and A/Prof Maree L. Hackett Status: Closed No….

ASSENT

A Phase 1b/2, Multi-Centre, Double-Blind, Placebo-Controlled, Randomized, Single-Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in…

ATTUNE

ATrial fibrillation in sTroke; Utility of Neuroimaging Evaluation Lead PI: Prof Mark Parsons Status: Recruiting No. of Patients Currently Recruited: 256                                No. of Patients…

AVERT

A Very Early Rehabilitation Trial AVERT is a Phase III, international, multicentre, single blind trial comparing earlier onset and higher…

avert dose logo revised
AVERT DOSE

A trial to Determine the Optimal early mobility Training after Stroke AVERT DOSE: A trial to Determine the Optimal early…

CHARM

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe…

COMPARE

Constraint Induced or Multi-Modal aphasia rehabilitation: A Randomised Controlled Trial (RCT) for stroke related chronic aphasia Lead PI: A/Prof Miranda Rose Status: Completed…

DIRECT-SAFE
DIRECT-SAFE

A randomised controlled trial of DIRECT endovascular clot retrieval versus standard bridging thrombolysis with endovascular clot retrieval within 4.5 hours…

ESCAPE NA-1

A Multicentre, Randomised, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Intravenous NA-1 in Subjects…

1 2 4